GlassScriptPhysician profile
Adva Kornblit
NPI 1609119031
$1,217.14
in general payments reported to CMS, 2019-2025
17 companies · $327 in 2025
The $327 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $19.12 · 2023: $247 · 2024: $624 · 2025: $327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,198.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $185.30 | 2023-2025 | Breztri, Airsupra, Farxiga |
| Glaxosmithkline, LLC. | $136.60 | 2023-2024 | Shingrix, Arexvy, Bexsero |
| Novo Nordisk INC | $117.31 | 2023-2025 | Wegovy |
| Abbvie INC. | $109.58 | 2022-2024 | |
| Lilly USA, LLC | $102.03 | 2023-2024 | Mounjaro |
| Amgen INC. | $90.89 | 2023-2025 | Repatha, Otezla, Evenity |
| Daiichi Sankyo INC. | $65.06 | 2024-2025 | Injectafer |
| Exact Sciences Corporation | $61.35 | 2025 | Cologuard Collection Kit |
| Abbott Laboratories | $53.79 | 2023-2025 | Freestyle Libre 3 |
| Astellas Pharma US INC | $45.73 | 2024 | Veozah |
| Sanofi-Aventis U.S. LLC | $44.43 | 2024 | |
| Pfizer INC. | $43.44 | 2024 | |
| Medtronic, INC. | $41.18 | 2024-2025 | Symplicity G3 |
| Tersera Therapeutics LLC | $33.21 | 2024 | Quzyttir |
| Inspire Medical Systems, INC. | $32.94 | 2024 | Inspire |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $29.36 | 2025 | Dexcom G6 Transmitter |
| Gilead Sciences, INC. | $24.94 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adva Kornblit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.